Saudi Medical Journal · 2014 · 28 citations · 13 references
MedicineMaternal HealthObstetricsMaternal-fetal MedicineMedication Safety PolicyReproductive MedicinePregnancyPrenatal CareAllied Health ProfessionalsDescriptive Statistics TablesPregnancy PrescribingPregnancy Safety InformationPregnancy UsePrescription Drug Pregnancy ClassificationUse In Pregnancy Statements
OBJECTIVE: To assess the knowledge and attitudes of healthcare professionals (HCPs) toward systems used in describing the safety of medications use during pregnancy. METHODS: A cross-sectional self-administered survey was conducted in 4 tertiary hospitals in Riyadh, Saudi Arabia between March and May 2012. The targeted HCPs were physicians and pharmacists. The survey was validated and contained 4 main sections. Descriptive statistics were used to report responses to the survey's questions. RESULTS: A total of 393 HCPs responded to the survey, with a response rate of 97%. Half of the respondents were physicians. Of the participants, 60% were males. Most respondents (66%) stated that they have prescribed/dispensed a drug that may cause teratogenicity. Moreover, 87% of the respondents (48% pharmacists and 39% physicians) were aware of the Food and Drug Administration (FDA) pregnancy category, and most (72%) found it helpful. Only 11% of the participants strongly agree to use the European Medicine Agency (EMA) system for pregnancy category system as their main reference. CONCLUSION: In general, HCPs in Saudi Arabian hospitals have good knowledge of and attitudes toward pregnancy category systems, with more familiarity with the FDA system. The FDA system is preferred over the EMA system.
13
Prescription drug use in pregnancy
Susan E. Andrade, Jerry H. Gurwitz, Robert L. Davis et al. · American Journal of Obstetrics and Gynecology · 2004 · 559 citations
Teratogenicity of recently introduced medications in human pregnancy
Wai–Kit Lo · Obstetrics and Gynecology · 2002 · 171 citations
Medicine, Obstetrics, Pharmacology +13
Risk Classification Systems for Drug Use During Pregnancy
Antonio Addis, Sherin Sharabi, Maurizio Bonati · Drug Safety · 2000 · 127 citations
Medicine, Obstetrics, Pharmacology +14
Prescription of Hazardous Drugs During Pregnancy
Heli Malm, Jaana E. Martikainen, Timo Klaukka et al. · Drug Safety · 2004 · 80 citations
Medicine, Obstetrics, Pharmacology +11